Cargando…
Clinical Treatment Experience in Severe and Critical COVID-19
Compared with other deadly diseases, the coronavirus disease 2019 (COVID-19) is highly infectious with a relatively low mortality rate. Although critical cases account for only 5% of cases, the mortality rate for the same is nearly 50%. Therefore, the key to the COVID-19 treatment is to effectively...
Autores principales: | Li, Mingliang, Zhu, Donglin, Yang, Jianghua, Yan, Ling, Xiong, Zhiyong, Lu, Jiahai, Bi, Xiaogang, Xi, Yun, Chen, Zeliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483935/ https://www.ncbi.nlm.nih.gov/pubmed/34602859 http://dx.doi.org/10.1155/2021/9924542 |
Ejemplares similares
-
T Cell Activating Thermostable Self‐Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery
por: Zhang, Jinsong, et al.
Publicado: (2023) -
Epidemiologic Characteristics, Transmission Chain, and Risk Factors of Severe Infection of COVID-19 in Tianjin, a Representative Municipality City of China
por: Wang, Jin, et al.
Publicado: (2020) -
Clinical descriptive analysis of severe Pneumocystis jirovecii pneumonia in renal transplantation recipients
por: Xie, Dan, et al.
Publicado: (2021) -
Factors Associated With Diagnostic Delays in Human Brucellosis in Tongliao City, Inner Mongolia Autonomous Region, China
por: Zhai, Jingbo, et al.
Publicado: (2021) -
The Emergence and Spread of Novel SARS-CoV-2 Variants
por: Yi, Huaimin, et al.
Publicado: (2021)